Abstract
In this article a review is given on the research strategies, on experimental work and application of ISOLDE produced radionuclides used in the field of biomedicine over a period of more than 2 decades. Special attention will be directed to the radio-lanthanides for several reasons: firstly, the radio-lanthanides are three-valent metallic radionuclides which show any radiation properties we wish (single photon emission suitable for SPECT, positron emission suitable for PET, β−- and Auger electron emission suitable for therapy). Even the alpha decay mode (suitable for therapy in selected cases) is available in the lanthanide group. Secondly, the 15 lanthanides can be seen chemically as one single element for labelling of tracer molecules, providing the unique possibility to study systematically relationships between physico-chemical molecule parameter and a biological response without changes in the basic tracer molecule. Very recent developments in bioconjugation chemistry call for three-valent metallic radionuclides for all kinds of nuclear medical application: diagnosis, in vivo dosimetry and radionuclide therapy where the rare-earth elements will play an important role in future.
Similar content being viewed by others
References
G.V. Hevesy, Biochem. J. 17 (1923) 439.
O. Chievitz and G.V. Hevesy, Nature 136 (1935) 754.
W.G. Myers and H.N. Wagner Jr., Nuclear medicine: How it began, in: Nuclear Medicine-A Hospital Practice Book, ed. H.N. Wagner Jr. (HP Publishing, 1975).
H.N. Wagner and G.T. Seaborg, Nuclear Medicine-100 Years in the Making 1896–1996, Special Issue of the Society of Nuclear Medicine (Reston, VA, 1996).
J.H.L. Lawrence and K.G. Scott, Proc. Soc. Exp. Biol. Med. 40 (1939) 694.
S. Hertz, A. Roberts and R.D. Evans, Proc. Soc. Exp. Biol. Med. 38 (1938) 510.
J.G. Hamilton and M.H. Soley, Am. J. Physiol. 131 (1940) 135.
G.J. Beyer, E. Herrmann, A. Piotrovski, V.I. Raiko and H. Tyrroff, Nucl. Instrum. Methods 96 (1971) 437.
G.J. Beyer, W.D. Fromm and A.F. Novgorodov, Nucl. Instrum. Methods 146 (1977) 419.
G.J. Beyer and A.F. Novgorodov, Radiochem. Radioanal. Lett. 25 (1976) 341.
G.J. Beyer, E. Hagebo, H.L. Ravn and A.F. Novgorodov, in: 3rd Internat. Conf. on Nuclear and Radiochemistry, Vienna (7–11 September 1992).
G.J. Beyer and A.F. Novgorodov, JINR P6–9917, Dubna (1996) and Report ZfK-305, Rossendorf (1976).
G.J. Beyer and H.L. Ravn, Internat. J. Radiat. Appl. Instrum., Part A: Appl. Radiat. Isot. 42 (1991) 141.
G.J. Beyer and H.L. Ravn, Nucl. Med. 30 (1991) A9.
G.J. Beyer, E. Herrmann and H. Tyrroff, Isotopenpraxis 13 (1977) 193.
M. Vobecky and A. Mastalka, Coll. Chechosl. Chem. Commun. 28 (1963) 709.
G.J. Beyer and H.L. Ravn, in: Proc. of 3rd Internat. Meeting on Nuclear Analytical Methods, Dresden (11–15 April 1983) ed. S. Niese (ZfK-524, Rossendorf, 1984) p. 520.
C.L. Edwards and R.L. Hayes, J. Nucl. Med. 10 (1969) 103.
K. Hisada and A. Ando, J. Nucl. Med. 14 (1973) 615.
T. Higashi, T. Fujimura et al., Kaku Igaku 10 (1973) 27.
J. Kano and Kanazawwa, Irigaku Sosho 96 (1974) 49.
A. Ando, K. Hisida, T. Hiraki et al., Radioisotopes (Tokyo) 23 (1974) 161.
K. Hisida, Y. Suzuki et al., Radiology 116 (1975) 389.
J.F. Chatal, B.P. LeMevel et al., Radiol. Electrol. Med. Nucl. 56 (1975) 401.
A. Ando, K. Hisida et al., Radioisotopes (Tokyo) 24 (1975) 109.
Y. Yano and P. Chu, Internat. J. Nucl. Med. Biol. 2 (1975) 135.
A. Kühne, W.G. Franke et al., Radiobiol. Radiotherap. 17 (1976) 111.
R.L. Hayes, D.H. Brown et al., J. Nucl. Med. 15 (1974) 501.
G.J. Beyer, R. Münze et al., in: Medical Radionuclide Imaging 1980, IAEA, Vienna (1981) Vol. 1 p. 587.
G.J. Beyer, W.G. Franke et al., Internat. J. Appl. Radiat. Isotopes 29 (1978) 673.
K. Schomäcker, D. Mocker, R. Münze and G.J. Beyer, Internat. J. Radiat. Appl. Instrum. Part A: Appl. Radiat. Isot. 39 (1988) 261.
B. Neumaier and F. Rösch, Radiochimica Acta 81 (1998) 171.
B. Neumaier and F. Rösch, Radiochimica Acta (1999) in print.
K. Schomäcker, W.G. Franke, E. Henke, W.D. Fromm, G. Maka and G.J. Beyer, European J. Nucl. Med. 11 (1986) 345.
W.G. Franke, Clinic of Nuclear Medicine, Clinicum of the TU Dresden (Image recorded 1980).
J. Kutzner, W. Dähnert, T. Schreyer et al., Nukl. Med. 20 (1981) 229.
G.J. Beyer, K. Schomäcker et al., in: Annual Report (1988), ed. R. Münze, ZfK-669, Rossendorf (1989) p. 98.
G.J. Beyer, R. Bergmann et al., Isotopenpraxis 26 (1990) 111.
W.F. Goeckeler, B. Edwards et al., J. Nucl. Med. 28 (1987) 495.
G.J. Beyer, R. Bergmann et al., Nucl. Med. Biology, Internat. J. Rad. Appl. Instrum. Part B 19 (1992) 201.
G.J. Beyer, G. Kampf and R. Bergmann, European J. Nuclear Med. 22 (1995) 914.
G.J. Beyer, R. Offord, G. Künzi, Yu. Aleksandrova, U. Ravn, S. Jahn, J. Backe, O. Tengblad, M. Lindroos and the ISOLDE Collaboration, Nucl. Med. Biology 24 (1997) 367.
D.J. Hnatovich, R.L. Childs, D. Lanteigne and A. Najafi, J. Immun. Methods 65 (1983) 147.
T. Moeller and L.C. Thompson, J. Inorg. Nucl. Chem. 24 (1962) 499.
T.F. Gritmon, M.P. Goedken and G.R. Choppin, J. Inorg. Nucl. Chem. 39 (1977) 2021.
M.W. Brechbiel, O.A. Gansow, R.W. Atcher et al., Inorg. Chem. 25 (1986) 2772.
H. Mäcke, Cantonal Hospital Basle, Div. Nuclear Medicine, Private communication (1994).
S. Pochon, F. Buchegger, A. Pelegrin et al., Internat. J. Cancer 43 (1989) 1188.
G.J. Beyer, R.E. Offord, G. Künzi, R.M.L. Jones, U. Ravn, Yu. Aleksandrova, R.C. Werlen, H. Mäcke, M. Lindroos, D. Tengblad and the ISOLDE Collaboration, J. Lab. Comp. Radiopharm. XXXVII (1995) 292.
E. Dadachova, S. Mirzadeh, S.V. Smith et al., Appl. Rad. Isot. 48 (1997) 477.
E.P. Krenning, D.J. Kwekkeboom, S. Pauwels, L.K. Kvols and J.C. Reubi, in: Nuclear Medicine Annual 199, ed. L.M. Freeman (Raven Press, New York, 1995) p. 1.
E.P. Krenning, D.J. Kwekkeboom, W.H. Bakker et al., European J. Nucl. Med. 20 (1993) 716.
J. Brockmann and F. Rösch, J. Lab. Comp. Radiopharm. XXXIX (1997) 471.
G.J. Beyer, R.E. Offord, R. Werlen, G. Künzi, Yu. Aleksandrova and the ISOLDE Collaboration, European J. Nucl. Med. 23 (1996) 1132.
G.J. Beyer, A. Donath, Ch. Morel, R. Offord, G. Künzi, U. Ravn, Yu. Aleksandrova, S. Jahn, M. Lindroos and the ISOLDE Collaboration, J. Nucl. Med. 35 (1996) 194.
H. Mäcke, S. Jahn, M. Lindroos, Yu. Aleksandrova, G.J. Beyer, R.M.L. Jones, G. Künzi, R.E. Offord, U. Ravn, R. Werlen, A. Donath, C. Morel, D. Slosman and F. Terrier, in: Experiments at CERN 1994, (CERN GREY BOOK) ISSN 0259–093X (CERN, 1994) p. 242 (see also the title page).
G.J. Beyer, A. Donath, D. Slosman et al., CERN-ISOLDE, Internal Report (1994).
G.J. Beyer, C. Morel, D. Slosman, S. Sakar, B.J. Allen and the ISOLDE Collaboration, European J. Nucl. Med. 25 (1998) 1157.
S.G. McDevritt, R.D. Finn, J.L. Humm et al., European J. Nucl. Med. 25 (1998) 1341.
G.J. Beyer, B.J. Allen, C. Morel, R. Offord, Yu. Aleksandrova, S. Jahn and the ISOLDE Collaboration, Nukl. Med. 35 (1996) A 100.
G.J. Beyer, R. Offord, B.J. Allen, G. Goozee, S. Imam, S. Sakar and J. Leigh, CERN-PPE/96–127, and in: Proc. of the 6th Internat. Conf. on Radiopharmaceutical Dosimetry, Gatlington, TN, USA (May 7–10, 1996).
A. Kovalik, V.M. Gorozhanskin, A.F. Novgorodov, M.A. Mahmoud, A. Minkova, G.J. Beyer, H.L. Ravn and Li Yong Ii, JINR E6–90–477, Dubna (1990).
Rights and permissions
About this article
Cite this article
Beyer, G. Radioactive ion beams for biomedical research and nuclear medical application. Hyperfine Interactions 129, 529–553 (2000). https://doi.org/10.1023/A:1012670018533
Issue Date:
DOI: https://doi.org/10.1023/A:1012670018533